Zobrazeno 1 - 10
of 28
pro vyhledávání: '"tania moccia"'
Autor:
Maria Serena Roca, Tania Moccia, Federica Iannelli, Cristina Testa, Carlo Vitagliano, Michele Minopoli, Rosa Camerlingo, Giulia De Riso, Rossella De Cecio, Francesca Bruzzese, Mariarosaria Conte, Lucia Altucci, Elena Di Gennaro, Antonio Avallone, Alessandra Leone, Alfredo Budillon
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-4 (2022)
Externí odkaz:
https://doaj.org/article/aef0412950b142b39fc68d0d1d8f347c
Autor:
Maria Serena Roca, Tania Moccia, Federica Iannelli, Cristina Testa, Carlo Vitagliano, Michele Minopoli, Rosa Camerlingo, Giulia De Riso, Rossella De Cecio, Francesca Bruzzese, Mariarosaria Conte, Lucia Altucci, Elena Di Gennaro, Antonio Avallone, Alessandra Leone, Alfredo Budillon
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-19 (2022)
Abstract Background Pancreatic ductal adenocarcinoma (PDAC) represents an unmet clinical need due to the very poor prognosis and the lack of effective therapy. Here we investigated the potential of domatinostat (4SC-202), a new class I histone deacet
Externí odkaz:
https://doaj.org/article/3dd4a1e22b6f4f1c864d52fcda8011ea
Autor:
Rita Lombardi, Maura Sonego, Biagio Pucci, Laura Addi, Federica Iannelli, Francesca Capone, Luigi Alfano, Maria Serena Roca, Maria Rita Milone, Tania Moccia, Alice Costa, Elena Di Gennaro, Francesca Bruzzese, Gustavo Baldassarre, Alfredo Budillon
Publikováno v:
Molecular Oncology, Vol 15, Iss 4, Pp 1005-1023 (2021)
Acquired resistance to platinum (Pt)‐based therapies is an urgent unmet need in the management of epithelial ovarian cancer (EOC) patients. Here, we characterized by an unbiased proteomics method three isogenic EOC models of acquired Pt resistance
Externí odkaz:
https://doaj.org/article/b460b33c2f544783a77170d47c26337c
Autor:
Federica Iannelli, Maria Serena Roca, Rita Lombardi, Chiara Ciardiello, Laura Grumetti, Simona De Rienzo, Tania Moccia, Carlo Vitagliano, Angela Sorice, Susan Costantini, Maria Rita Milone, Biagio Pucci, Alessandra Leone, Elena Di Gennaro, Rita Mancini, Gennaro Ciliberto, Francesca Bruzzese, Alfredo Budillon
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 39, Iss 1, Pp 1-24 (2020)
Abstract Background Despite the introduction of several novel therapeutic approaches that improved survival, metastatic castration-resistant prostate cancer (mCRPC) remains an incurable disease. Herein we report the synergistic antitumor interaction
Externí odkaz:
https://doaj.org/article/e79dabb2f2a0410392c345de926e0f74
Autor:
Chiara Ciardiello, Alessandra Leone, Paola Lanuti, Maria S. Roca, Tania Moccia, Valentina R. Minciacchi, Michele Minopoli, Vincenzo Gigantino, Rossella De Cecio, Massimo Rippa, Lucia Petti, Francesca Capone, Carlo Vitagliano, Maria R. Milone, Biagio Pucci, Rita Lombardi, Federica Iannelli, Elena Di Gennaro, Francesca Bruzzese, Marco Marchisio, Maria V. Carriero, Dolores Di Vizio, Alfredo Budillon
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-16 (2019)
Abstract Background Molecular markers for prostate cancer (PCa) are required to improve the early definition of patient outcomes. Atypically large extracellular vesicles (EVs), referred as “Large Oncosomes” (LO), have been identified in highly mi
Externí odkaz:
https://doaj.org/article/df0b835cb5874271a1a89640e6d4f5e9
Autor:
Federica Iannelli, Andrea Ilaria Zotti, Maria Serena Roca, Laura Grumetti, Rita Lombardi, Tania Moccia, Carlo Vitagliano, Maria Rita Milone, Chiara Ciardiello, Francesca Bruzzese, Alessandra Leone, Ernesta Cavalcanti, Rossella De Cecio, Giuseppina Iachetta, Salvatore Valiante, Franco Ionna, Francesco Caponigro, Elena Di Gennaro, Alfredo Budillon
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 8 (2020)
Recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) is a devastating malignancy with a poor prognosis. The combination of cisplatin (CDDP) plus cetuximab (CX) is one of the standard first-line treatments in this disease. However, t
Externí odkaz:
https://doaj.org/article/322d6309ee924382b66d5dcdaf5dbda5
Autor:
Davide Melisi, James L. Abbruzzese, Paul J. Chiao, Alfredo Budillon, Genni Paradiso, Cihui Zhu, Tania Moccia, Carmine Carbone
Purpose: The resistance of tumors to antiangiogenic therapies is becoming increasingly relevant. There are currently no validated predictive biomarkers for selecting which cancer patients will benefit from antiangiogenic therapy. Also lacking are res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::049429ea92006234d46ddead2cd769aa
https://doi.org/10.1158/1078-0432.c.6519875.v1
https://doi.org/10.1158/1078-0432.c.6519875.v1
Autor:
Davide Melisi, James L. Abbruzzese, Paul J. Chiao, Alfredo Budillon, Genni Paradiso, Cihui Zhu, Tania Moccia, Carmine Carbone
PDF file - 298K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c98a051c27d704ef2fe18fe731398383
https://doi.org/10.1158/1078-0432.22443572
https://doi.org/10.1158/1078-0432.22443572
Autor:
Maria Rita Milone, Francesca Capone, Tania Moccia, Laura Addi, María Roca, Biagio Pucci, Elena Di Gennaro, Francesca Bruzzese, Maura Sonego, Alfredo Budillon, Alice Costa, Gustavo Baldassarre, Federica Iannelli, Rita Lombardi, Luigi Alfano
Publikováno v:
Molecular Oncology, Vol 15, Iss 4, Pp 1005-1023 (2021)
Molecular Oncology
Molecular Oncology
Acquired resistance to platinum (Pt)‐based therapies is an urgent unmet need in the management of epithelial ovarian cancer (EOC) patients. Here, we characterized by an unbiased proteomics method three isogenic EOC models of acquired Pt resistance
Autor:
Maria Serena Roca, federica iannelli, maria rita milone, veronica barile, cristina testa, tania moccia, carlo vitagliano, fabiana tatangelo, di gennaro elena, antonio avallone, francesca bruzzese, alessandra leone, alfredo budillon
Publikováno v:
Cancer Research. 82:1840-1840
INTRODUCTION: Metastatic pancreatic ductal adenocarcinoma (PDAC) represents an unmet clinical need because the lack of effective treatment strategies and a very poor prognosis. Here we propose a novel therapeutic strategy, based on the repurposing of